J.A.S. Crippa

2.2k total citations
31 papers, 1.6k citations indexed

About

J.A.S. Crippa is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, J.A.S. Crippa has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Clinical Psychology. Recurrent topics in J.A.S. Crippa's work include Cannabis and Cannabinoid Research (13 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). J.A.S. Crippa is often cited by papers focused on Cannabis and Cannabinoid Research (13 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). J.A.S. Crippa collaborates with scholars based in Brazil, United Kingdom and Spain. J.A.S. Crippa's co-authors include Antônio Waldo Zuardi, Jaime E. C. Hallak, Francisco Silveira Guimarães, Fabrício A. Moreira, João Quevedo, Cristina Marta Del‐Ben, Rocı́o Martı́n-Santos, Gislaine Z. Réus, Roberto B. Stringari and José Antônio Alves Vilela and has published in prestigious journals such as Scientific Reports, Brain Research and Psychological Medicine.

In The Last Decade

J.A.S. Crippa

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.A.S. Crippa Brazil	19	930	548	355	293	278	31	1.6k
R. Andrew Sewell United States	22	752 0.8×	727 1.3×	256 0.7×	279 1.0×	546 2.0×	36	1.8k
Francisco Navarrete Spain	28	1.3k 1.4×	1.0k 1.9×	357 1.0×	172 0.6×	200 0.7×	95	2.4k
Gabriel Braley United States	9	1.4k 1.5×	795 1.5×	318 0.9×	477 1.6×	226 0.8×	10	1.7k
Mateus M. Bergamaschi Brazil	15	1.7k 1.8×	510 0.9×	371 1.0×	193 0.7×	216 0.8×	24	2.0k
Ziva D. Cooper United States	33	2.0k 2.2×	1.0k 1.9×	278 0.8×	249 0.8×	378 1.4×	103	2.9k
Lisa Macdougall United States	5	786 0.8×	505 0.9×	241 0.7×	269 0.9×	123 0.4×	5	1.1k
Chandni Hindocha United Kingdom	28	1.9k 2.0×	644 1.2×	457 1.3×	322 1.1×	448 1.6×	52	2.4k
Eef L. Theunissen Netherlands	32	1.7k 1.8×	914 1.7×	480 1.4×	223 0.8×	923 3.3×	94	3.0k
José Alexandre S. Crippa Brazil	22	2.1k 2.3×	859 1.6×	587 1.7×	370 1.3×	616 2.2×	45	3.0k
Christopher D. Verrico United States	23	672 0.7×	830 1.5×	251 0.7×	199 0.7×	280 1.0×	58	1.5k

Countries citing papers authored by J.A.S. Crippa

Since Specialization

Citations

This map shows the geographic impact of J.A.S. Crippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A.S. Crippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A.S. Crippa more than expected).

Fields of papers citing papers by J.A.S. Crippa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A.S. Crippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A.S. Crippa. The network helps show where J.A.S. Crippa may publish in the future.

Co-authorship network of co-authors of J.A.S. Crippa

This figure shows the co-authorship network connecting the top 25 collaborators of J.A.S. Crippa. A scholar is included among the top collaborators of J.A.S. Crippa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A.S. Crippa. J.A.S. Crippa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martins, Ronaldo B., Franciele Franco Scarante, Sabrina Setembre Batah, et al.. (2024). Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain Behavior & Immunity - Health. 41. 100855–100855. 1 indexed citations

Mendes, Ana Vilela, Sônia Regina Loureiro, Rocı́o Martı́n-Santos, et al.. (2023). DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression. Journal of Affective Disorders. 331. 287–299. 9 indexed citations

Bellissimo‐Rodrigues, Fernando, Fernanda de Lima Moreira, Joseane Cristina Ferreira, et al.. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports. 12(1). 6454–6454. 37 indexed citations

Crippa, J.A.S., Ana Vilela Mendes, Sônia Regina Loureiro, et al.. (2018). Epigenetic variation at the SLC6A4 gene promoter in mother–child pairs with major depressive disorder. Journal of Affective Disorders. 245. 716–723. 18 indexed citations

Batalla, Albert, Valentina Lorenzetti, Yann Chye, et al.. (2018). The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users. Cannabis and Cannabinoid Research. 3(1). 1–10. 12 indexed citations

Linares, Ila Marques Porto, Antônio Waldo Zuardi, Regina Helena Costa Queiróz, et al.. (2016). Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test. European Neuropsychopharmacology. 26. S617–S617. 24 indexed citations

Gobira, Pedro H., Luciano Vilela, Antônio Carlos de Oliveira, et al.. (2015). Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release. NeuroToxicology. 50. 116–121. 74 indexed citations

Bhattacharyya, Sagnik, Conrad Iyegbe, Zerrin Atakan, et al.. (2014). Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychological Medicine. 44(15). 3315–3328. 33 indexed citations

Pujol, Jesús, Laura Blanco‐Hinojo, Albert Batalla, et al.. (2014). Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users. Journal of Psychiatric Research. 51. 68–78. 77 indexed citations

10.

Gobira, Pedro H., et al.. (2013). Animal models for predicting the efficacy and side effects of antipsychotic drugs. Brazilian Journal of Psychiatry. 35(suppl 2). S132–S139. 43 indexed citations

11.

Crippa, J.A.S., et al.. (2012). Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature. Harm Reduction Journal. 9(1). 7–7. 24 indexed citations

12.

Crippa, J.A.S., et al.. (2012). Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports. Therapeutic Advances in Psychopharmacology. 3(2). 83–88. 4 indexed citations

13.

Garcia, Vanessa Athaíde, Natasha Maurmann, Jaime E. C. Hallak, et al.. (2011). Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology. 219(4). 1133–1140. 75 indexed citations

14.

Levitan, Michelle N., Marcos Hortes Nisihara Chagas, J.A.S. Crippa, et al.. (2011). Diretrizes da Associação Médica Brasileira para o tratamento do transtorno de ansiedade social. Brazilian Journal of Psychiatry. 33(3). 292–302. 11 indexed citations

15.

Fortunato, Jucélia Jeremias, Gislaine Z. Réus, Roberto B. Stringari, et al.. (2010). Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. Journal of Neural Transmission. 117(10). 1131–1137. 72 indexed citations

16.

Réus, Gislaine Z., Roberto B. Stringari, Fabrícia Petronilho, et al.. (2010). Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus. Oxidative Medicine and Cellular Longevity. 3(5). 325–331. 88 indexed citations

17.

Bhattacharyya, Sagnik, Paolo Fusar‐Poli, Stefan Borgwardt, et al.. (2009). Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol. Archives of General Psychiatry. 66(4). 442–442. 192 indexed citations

18.

Fortunato, Jucélia Jeremias, Gislaine Z. Réus, Roberto B. Stringari, et al.. (2009). Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(8). 1425–1430. 111 indexed citations

19.

Uchida, Ricardo Riyoiti, Cristina Marta Del‐Ben, Geraldo F. Busatto, et al.. (2008). Regional gray matter abnormalities in panic disorder: A voxel-based morphometry study. Psychiatry Research Neuroimaging. 163(1). 21–29. 121 indexed citations

20.

Santos, Marcel Koenigkam, Antônio Carlos dos Santos, Beatriz R. Versiani, et al.. (2008). Whole-Brain Voxel-Based Morphometry in Kallmann Syndrome Associated with Mirror Movements. American Journal of Neuroradiology. 29(9). 1799–1804. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact